RITES Share Price in Focus; CMD Rahul Mithal's Tenure Extended till June 2027

RITES will continue to have Rahul Mithal as its Chairman and Managing Director for longer than originally planned, as per the exchange filings.
The Ministry of Railways approved the extension of his tenure beyond October 6, 2026, when his existing term was scheduled to end.
Mithal to Stay on Until June 2027
The extension will keep Mithal in the CMD position until June 30, 2027, which is his date of superannuation. The order also says the extension will remain valid until further orders if that comes earlier.
The Ministry of Railways informed RITES about the decision through a letter dated August 20, 2026.
Company Completing Formalities
RITES said it is now working through the formalities needed to give effect to the extension. Further disclosure will be made separately once the relevant process is completed.
The filing itself does not give any reason for the extension or mention any new targets linked to Mithal's continued tenure.
About RITES
RITES Limited is a government-owned engineering and consultancy company under the Ministry of Railways. Its business includes engineering, consultancy and project management work across transport infrastructure, with railways forming a major part of its operations.
The company also works in areas such as urban transport, highways, airports and ports, along with services related to rolling stock.
Read More: Saatvik Green Energy Share Price Surges Over 3%; Secures ₹190 Crore Solar PV Module Order!
RITES Share Price Performance
As of 21 August 2026, at 12:31 PM, RITES Ltd share price is trading at ₹218.11 per share, reflecting a decline of 0.15% from the previous trading session.
Conclusion
The Ministry of Railways has approved Rahul Mithal's tenure as RITES CMD until June 30, 2027, or until further orders, whichever is earlier. RITES is completing the formalities related to the extension.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Aug 21, 2026, 1:41 PM IST

Team Angel One
- Brigade Enterprises Share Price Gains Over 6% as it Secures Lease Agreement with HealthEdge in Thiruvananthapuram
- BL Kashyap Share Price Gains Over 3%; Secures ₹183.18 Crore Order from Realkraft Ventures
- Mankind Pharma Share Price in Focus; Partners with Chongqing Chenan Biopharmaceutical for Insulin Analogues
- RVNL Share Price Surges Over 2%; Receives ₹161.02 Crore Order from East Coast Railway
- Strides Pharma Share Price Surges 3%; Receives USFDA EIR for Bengaluru Facility


